Bone Solutions gets FDA 510(k) clearance for bone void filler

Orthobiologics technology company Bone Solutions has received FDA 510(k) clearance for its Mg Osteorevive bone void filler, according to a Feb. 2 news release shared with Becker’s.

Advertisement

Mg Osteorevive is a moldable, magnesium-based injectable for use in posterolateral spine fusion procedures. The company said it chose magnesium as the key component for its product because of its strength and elasticity that closely resembles human bone. 

The product is being distributed to facilities and surgical centers nationwide for immediate clinical use, the Colleyville, Texas-based company said.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.